WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (47)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ballard, T. M.
Right arrow Articles by Kew, J. N. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ballard, T. M.
Right arrow Articles by Kew, J. N. C.

 Previous Article  |  Next Article 

The Journal of Neuroscience, August 1, 2002, 22(15):6713-6723

Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating Hyperactivity

Theresa M. Ballard1, *, Meike Pauly-Evers2, *, Guy A. Higgins1, Abdel-Mouttalib Ouagazzal1, Vincent Mutel1, Edilio Borroni1, John A. Kemp1, Horst Bluethmann2, and James N. C. Kew1

1 Preclinical CNS Research and 2 Roche Genetics, F. Hoffmann-La Roche Limited, CH-4070 Basel, Switzerland

NMDA receptor hypofunction has been implicated in the pathophysiology of schizophrenia, and pharmacological and genetic approaches have been used to model such dysfunction. We previously have described two mouse lines carrying point mutations in the NMDA receptor glycine binding site, Grin1D481N and Grin1K483Q, which exhibit 5- and 86-fold reductions in receptor glycine affinity, respectively. Grin1D481N animals exhibit a relatively mild phenotype compatible with a moderate reduction in NMDA receptor function, whereas Grin1K483Q animals die shortly after birth. In this study we have characterized compound heterozygote Grin1D481N/K483Q mice, which are viable and exhibited biphasic NMDA receptor glycine affinities compatible with the presence of each of the two mutated alleles. Grin1D481N/K483Q mice exhibited a marked NMDA receptor hypofunction revealed by deficits in hippocampal long-term potentiation, which were rescued by the glycine site agonist D-serine, which also facilitated NMDA synaptic currents in mutant, but not in wild-type, mice. Analysis of striatal monoamine levels revealed an apparent dopaminergic and serotonergic hyperfunction. Behaviorally, Grin1D481N/K483Q mice were insensitive to acute dizocilpine pretreatment and exhibited increased startle response but normal prepulse inhibition. Most strikingly, mutant mice exhibited a sustained, nonhabituating hyperactivity and increased stereotyped behavior that were resistant to suppression by antipsychotics and the benzodiazepine site agonist Zolpidem. They also displayed a disruption of nest building behavior and were unable to perform a cued learning paradigm in the Morris water maze. We speculate that the severity of NMDA receptor hypofunction in these mice may account for their profound behavioral phenotype and insensitivity to antipsychotics.

Key words: NMDA receptor; glycine site; schizophrenia; NMDAR1; Grin1; antipsychotics


* T.M.B. and M.P.-E. contributed equally to this work.


Copyright © 2002 Society for Neuroscience  0270-6474/02/22156713-11$05.00/0


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
A. Mouri, Y. Noda, A. Noda, T. Nakamura, T. Tokura, Y. Yura, A. Nitta, H. Furukawa, and T. Nabeshima
Involvement of a Dysfunctional Dopamine-D1/N-Methyl-D-aspartate-NR1 and Ca2+/Calmodulin-Dependent Protein Kinase II Pathway in the Impairment of Latent Learning in a Model of Schizophrenia Induced by Phencyclidine
Mol. Pharmacol., June 1, 2007; 71(6): 1598 - 1609.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. L. Meur, M. Galante, M. C. Angulo, and E. Audinat
Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus
J. Physiol., April 15, 2007; 580(2): 373 - 383.
[Abstract] [Full Text] [PDF]


Home page
Biol. Bull.Home page
T. J. Ha, A. B. Kohn, Y. V. Bobkova, and L. L. Moroz
Molecular Characterization of NMDA-Like Receptors in Aplysia and Lymnaea: Relevance to Memory Mechanisms
Biol. Bull., June 1, 2006; 210(3): 255 - 270.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
N. Hiroi, H. Zhu, M. Lee, B. Funke, M. Arai, M. Itokawa, R. Kucherlapati, B. Morrow, T. Sawamura, and S. Agatsuma
A 200-kb region of human chromosome 22q11.2 confers antipsychotic-responsive behavioral abnormalities in mice
PNAS, December 27, 2005; 102(52): 19132 - 19137.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P. Moretti, J. A. Bouwknecht, R. Teague, R. Paylor, and H. Y. Zoghbi
Abnormalities of social interactions and home-cage behavior in a mouse model of Rett syndrome
Hum. Mol. Genet., January 15, 2005; 14(2): 205 - 220.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
P. Svenningsson, G. G. Nomikos, and P. Greengard
Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Science, July 9, 2004; 305(5681): 180d - 180d.
[Full Text] [PDF]


Home page
J. Neurosci.Home page
D. M. Shin, S. Korada, R. Raballo, C. S. Shashikant, A. Simeone, J. R. Taylor, and F. Vaccarino
Loss of Glutamatergic Pyramidal Neurons in Frontal and Temporal Cortex Resulting from Attenuation of FGFR1 Signaling Is Associated with Spontaneous Hyperactivity in Mice
J. Neurosci., March 3, 2004; 24(9): 2247 - 2258.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Miyakawa, L. M. Leiter, D. J. Gerber, R. R. Gainetdinov, T. D. Sotnikova, H. Zeng, M. G. Caron, and S. Tonegawa
Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia
PNAS, July 22, 2003; 100(15): 8987 - 8992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. F. Schwindinger, K. S. Betz, K. E. Giger, A. Sabol, S. K. Bronson, and J. D. Robishaw
Loss of G Protein gamma 7 Alters Behavior and Reduces Striatal alpha olf Level and cAMP Production
J. Biol. Chem., February 14, 2003; 278(8): 6575 - 6579.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-